China Eosinophilic Esophagitis Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.

    This report elaborates on the current development of the Eosinophilic Esophagitis Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Regeneron

    • Dr Falk Pharma

    • Calypso

    • Quorum Innovations

    • Bayer

    • Adare Pharmaceuticals

    • Shire

    • DBV Technologies

    • Celgene

    By Type:

    • Fluticasone

    • Others

    • Budesonide

    By Application:

    • Drugstore

    • Clinics

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Eosinophilic Esophagitis Drug Market Overview 2018-2029

    • 1.1 China Eosinophilic Esophagitis Drug Industry Development Overview

    • 1.2 China Eosinophilic Esophagitis Drug Industry Development History

    • 1.3 China Eosinophilic Esophagitis Drug Industry Market Size (2018-2029)

    • 1.4 China Eosinophilic Esophagitis Drug Market Analysis by Type from Production Side

      • 1.4.1 China Eosinophilic Esophagitis Drug Production Volume, Production Value and Growth Rate of Fluticasone (2018-2029)

      • 1.4.2 China Eosinophilic Esophagitis Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Eosinophilic Esophagitis Drug Production Volume, Production Value and Growth Rate of Budesonide (2018-2029)

    • 1.5 China Eosinophilic Esophagitis Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Eosinophilic Esophagitis Drug Sales Volume, Sales Value and Growth Rate of Drugstore (2018-2029)

      • 1.5.2 China Eosinophilic Esophagitis Drug Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.3 China Eosinophilic Esophagitis Drug Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Eosinophilic Esophagitis Drug Market Analysis by Region

      • 1.6.1 North China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Eosinophilic Esophagitis Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Eosinophilic Esophagitis Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Eosinophilic Esophagitis Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Eosinophilic Esophagitis Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Eosinophilic Esophagitis Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Eosinophilic Esophagitis Drug Industry Development

    Chapter 3 Eosinophilic Esophagitis DrugIndustry Chain Analysis

    • 3.1 Eosinophilic Esophagitis Drug Industry Chain

    • 3.2 Eosinophilic Esophagitis Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Eosinophilic Esophagitis Drug Market

    • 3.3 Eosinophilic Esophagitis Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Eosinophilic Esophagitis Drug Market

    Chapter 4 China Eosinophilic Esophagitis Drug Market, by Type

    • 4.1 China Eosinophilic Esophagitis Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Eosinophilic Esophagitis Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Eosinophilic Esophagitis Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Eosinophilic Esophagitis Drug Production Volume and Growth Rate of Fluticasone

      • 4.5.2 China Eosinophilic Esophagitis Drug Production Volume and Growth Rate of Others

      • 4.5.3 China Eosinophilic Esophagitis Drug Production Volume and Growth Rate of Budesonide

    Chapter 5 China Eosinophilic Esophagitis Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Eosinophilic Esophagitis Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Eosinophilic Esophagitis Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Eosinophilic Esophagitis Drug Market Size and Growth Rate of Drugstore

      • 5.5.2 China Eosinophilic Esophagitis Drug Market Size and Growth Rate of Clinics

      • 5.5.3 China Eosinophilic Esophagitis Drug Market Size and Growth Rate of Hospitals

    Chapter 6 China Eosinophilic Esophagitis Drug Market, by Region

    • 6.1 China Eosinophilic Esophagitis Drug Production Volume and Production Value, by Region

    • 6.2 China Eosinophilic Esophagitis Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Eosinophilic Esophagitis Drug Market Analysis

    • 7.1 North China Eosinophilic Esophagitis Drug Market, by Type

    • 7.2 North China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 8 Central China Eosinophilic Esophagitis Drug Market Analysis

    • 8.1 Central China Eosinophilic Esophagitis Drug Market, by Type

    • 8.2 Central China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 9 South China Eosinophilic Esophagitis Drug Market Analysis

    • 9.1 South China Eosinophilic Esophagitis Drug Market, by Type

    • 9.2 South China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 10 East China Eosinophilic Esophagitis Drug Market Analysis

    • 10.1 East China Eosinophilic Esophagitis Drug Market, by Type

    • 10.2 East China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 11 Northeast China Eosinophilic Esophagitis Drug Market Analysis

    • 11.1 Northeast China Eosinophilic Esophagitis Drug Market, by Type

    • 11.2 Northeast China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 12 Southwest China Eosinophilic Esophagitis Drug Market Analysis

    • 12.1 Southwest China Eosinophilic Esophagitis Drug Market, by Type

    • 12.2 Southwest China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 13 Northwest China Eosinophilic Esophagitis Drug Market Analysis

    • 13.1 Northwest China Eosinophilic Esophagitis Drug Market, by Type

    • 13.2 Northwest China Eosinophilic Esophagitis Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Regeneron

        • 14.1.1 Regeneron Company Profile

        • 14.1.2 Regeneron Eosinophilic Esophagitis Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Dr Falk Pharma

        • 14.2.1 Dr Falk Pharma Company Profile

        • 14.2.2 Dr Falk Pharma Eosinophilic Esophagitis Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Calypso

        • 14.3.1 Calypso Company Profile

        • 14.3.2 Calypso Eosinophilic Esophagitis Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Quorum Innovations

        • 14.4.1 Quorum Innovations Company Profile

        • 14.4.2 Quorum Innovations Eosinophilic Esophagitis Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Bayer

        • 14.5.1 Bayer Company Profile

        • 14.5.2 Bayer Eosinophilic Esophagitis Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Adare Pharmaceuticals

        • 14.6.1 Adare Pharmaceuticals Company Profile

        • 14.6.2 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Shire

        • 14.7.1 Shire Company Profile

        • 14.7.2 Shire Eosinophilic Esophagitis Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 DBV Technologies

        • 14.8.1 DBV Technologies Company Profile

        • 14.8.2 DBV Technologies Eosinophilic Esophagitis Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Celgene

        • 14.9.1 Celgene Company Profile

        • 14.9.2 Celgene Eosinophilic Esophagitis Drug Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Eosinophilic Esophagitis Drug Industry Research Conclusions

    • 15.2 Eosinophilic Esophagitis Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Eosinophilic Esophagitis Drug Industry Market Size (2018-2029)

    • Figure China Eosinophilic Esophagitis Drug Production Volume, Production Value and Growth Rate of Fluticasone (2018-2029)

    • Figure China Eosinophilic Esophagitis Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Eosinophilic Esophagitis Drug Production Volume, Production Value and Growth Rate of Budesonide (2018-2029)

    • Figure China Eosinophilic Esophagitis Drug Sales Volume, Sales Value and Growth Rate of Drugstore (2018-2029)

    • Figure China Eosinophilic Esophagitis Drug Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Eosinophilic Esophagitis Drug Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Eosinophilic Esophagitis Drug Market Size and Growth Rate from 2018-2029

    • Figure Eosinophilic Esophagitis Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Eosinophilic Esophagitis Drug Market Share by Type in 2018

    • Figure China Eosinophilic Esophagitis Drug Market Share by Type in 2023

    • Figure China Eosinophilic Esophagitis Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Production Volume and Growth Rate of Fluticasone (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Production Volume and Growth Rate of Budesonide (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Market Share by Application in 2018

    • Figure China Eosinophilic Esophagitis Drug Market Share by Application in 2023

    • Figure China Eosinophilic Esophagitis Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Eosinophilic Esophagitis Drug Market Size and Growth Rate of Drugstore (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Production Volume by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Production Volume Share by Region (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Production Volume Share by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Production Value by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Production Value Share by Region (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Production Value Share by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Sales Volume by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Sales Volume Share by Region (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Sales Volume Share by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Sales Value by Region (2018-2023)

    • Table China Eosinophilic Esophagitis Drug Sales Value Share by Region (2018-2023)

    • Figure China Eosinophilic Esophagitis Drug Sales Value Share by Region (2018-2023)

    • Table North China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table North China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure North China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table North China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table North China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table Central China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table Central China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table Central China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table South China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table South China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure South China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table South China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table South China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table East China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table East China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure East China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table East China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table East China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table Northeast China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table Southwest China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Eosinophilic Esophagitis Drug Production Volume by Type (2018-2023)

    • Table Northwest China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Eosinophilic Esophagitis Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Eosinophilic Esophagitis Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Eosinophilic Esophagitis Drug Sales Volume Share by Application (2018-2023)

    • Table Regeneron Company Profile

    • Table Regeneron Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Dr Falk Pharma Company Profile

    • Table Dr Falk Pharma Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Calypso Company Profile

    • Table Calypso Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Quorum Innovations Company Profile

    • Table Quorum Innovations Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Adare Pharmaceuticals Company Profile

    • Table Adare Pharmaceuticals Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Shire Company Profile

    • Table Shire Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table DBV Technologies Company Profile

    • Table DBV Technologies Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)

    • Table Celgene Company Profile

    • Table Celgene Eosinophilic Esophagitis Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.